Showing results (41-50 of 50) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 26, 2016
[A Case of Anal Canal Carcinoma with Inguinal Lymph Node Metastasis Treated with Laparoscopic Abdominoperineal Resection]Toru Tonooka, Nobuhiro Takiguchi, Hiroshi Yamamoto, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 4, 2015
[Intraperitoneal chemotherapy with CDDP for patients with peritoneal recurrent gastric cancer following surgical intervention]Nobuhiro Takiguchi, Yoshihiro Nabeya, Atsushi Ikeda, et al.Journal of Hepato-Biliary-Pancreatic Surgery|April 9, 2008
Renal cell carcinoma with unusual metastasis to the gallbladderHiroyuki Nojima, Akihiro Cho, Hiroshi Yamamoto, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 31, 2017
[The Present Status of Surgical and Endoscopic Treatment for Gastric Cancer Patients Aged 85 Years or Older]Nobuhiro Takiguchi, Yoshihiro Nabeya, Reiri Shimazaki, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 16, 2015
[A Case of Early Recurrence after Esophagectomy for Cancer Following Neoadjuvant Chemotherapy Resulting in a Complete Response of the Primary Lesion]Hiroshige Saito, Yoshihiro Nabeya, Nobuhiro Takiguchi, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 6, 2019
[A Case of Boderline Resectable Pancreatic Cancer Curatively Resected after Chemotherapy with Gemcitabine and Nab-Paclitaxel]Naoki Kuwayama, Toshiyuki Natsume, Osamu Kainuma, et al.Lancet (London, England)|June 7, 2016
Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01)Katsuhiko Uesaka, Narikazu Boku, Akira Fukutomi, et al.Journal of Gastroenterology|April 24, 2015
NY-ESO-1 autoantibody as a tumor-specific biomarker for esophageal cancer: screening in 1969 patients with various cancersYoko Oshima, Hideaki Shimada, Satoshi Yajima, et al.European Journal of Cancer (Oxford, England : 1990)|February 26, 2018
Health-related quality of life of adjuvant chemotherapy with S-1 versus gemcitabine for resected pancreatic cancer: Results from a randomised phase III trial (JASPAC 01)Yasuhiro Hagiwara, Yasuo Ohashi, Katsuhiko Uesaka, et al.Cancer Science|November 29, 2019
Human equilibrative nucleoside transporter-1 expression is a predictor in patients with resected pancreatic cancer treated with adjuvant S-1 chemotherapyYukiyasu Okamura, Satoru Yasukawa, Hiroto Narimatsu, et al.Pageof 5